These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 23314858)

  • 1. Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation.
    Werner KT; Sando S; Carey EJ; Vargas HE; Byrne TJ; Douglas DD; Harrison ME; Rakela J; Aqel BA
    Dig Dis Sci; 2013 Jun; 58(6):1776-80. PubMed ID: 23314858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
    Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation treatment of portal vein thrombosis in a patient with cirrhosis awaiting liver transplantation: A case report.
    Wang J; Chai JS; Zhang YM
    Medicine (Baltimore); 2018 Jun; 97(26):e11183. PubMed ID: 29952969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.
    Bergère M; Erard-Poinsot D; Boillot O; Valette PJ; Guillaud O; Chambon-Augoyard C; Dumortier J
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):395-402. PubMed ID: 30578107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up to 50% of portal vein thrombosis remains undiagnosed until liver transplantation.
    Bert J; Geerts A; Vanlander A; Abreu de Carvalho L; Degroote H; Berrevoet F; Rogiers X; van Vlierberghe H; Verhelst X
    Clin Transplant; 2020 Dec; 34(12):e14107. PubMed ID: 33030231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis.
    Chung JW; Kim GH; Lee JH; Ok KS; Jang ES; Jeong SH; Kim JW
    Clin Mol Hepatol; 2014 Dec; 20(4):384-91. PubMed ID: 25548745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Oral Anticoagulants as Prophylaxis of Recurrent Portal Thrombosis after Liver Transplantation.
    Sanchez-Ocaña R; Tejedor-Tejada J; Cimavilla-Roman M; de Benito-Sanz M; Asensio-Diaz E; Barrera-Rebollo A; Perez-Saborido B; Garcia-Pajares F; Almohalla-Alvarez C; Sanchez-Antolin G
    Transplant Proc; 2019; 51(1):83-86. PubMed ID: 30655140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of factors related to recanalization of portal vein thrombosis in liver cirrhosis: a retrospective cohort study.
    Shi Y; Feng W; Cai J; Wang Z; Pu Y; Mao W; Zhan K; Chen D
    BMC Gastroenterol; 2024 Jul; 24(1):224. PubMed ID: 39003447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portal vein thrombosis: yes or no on anticoagulation therapy.
    Turon F; Hernández-Gea V; García-Pagán JC
    Curr Opin Organ Transplant; 2018 Apr; 23(2):250-256. PubMed ID: 29432256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portal vein thrombosis after laparoscopic sleeve gastrectomy: presentation and management.
    Belnap L; Rodgers GM; Cottam D; Zaveri H; Drury C; Surve A
    Surg Obes Relat Dis; 2016 Dec; 12(10):1787-1794. PubMed ID: 27178606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis.
    Hanafy AS; Abd-Elsalam S; Dawoud MM
    Vascul Pharmacol; 2019 Feb; 113():86-91. PubMed ID: 29886103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Liver transplantation for the patients with end stage liver disease and portal vein thrombosis].
    Gao PJ; Zhu JY; Li GM; Leng XS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):558-60. PubMed ID: 19829674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
    Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
    J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
    Fujiyama S; Saitoh S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
    BMC Gastroenterol; 2017 Oct; 17(1):112. PubMed ID: 29070023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis.
    Artaza T; Lopes M; Romero M; Gómez AZ; de la Cruz G; Sánchez JJ; González C; Gómez R
    Gastroenterol Hepatol; 2018 Dec; 41(10):611-617. PubMed ID: 30049580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis.
    John BV; Konjeti R; Aggarwal A; Lopez R; Atreja A; Miller C; Zein NN; Carey WD
    Ann Hepatol; 2013; 12(6):952-8. PubMed ID: 24114826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretransplantation Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Final Analysis of a 61-Patient Cohort.
    Thornburg B; Desai K; Hickey R; Hohlastos E; Kulik L; Ganger D; Baker T; Abecassis M; Caicedo JC; Ladner D; Fryer J; Riaz A; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2017 Dec; 28(12):1714-1721.e2. PubMed ID: 29050854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis.
    Chen H; Liu L; Qi X; He C; Wu F; Fan D; Han G
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):82-9. PubMed ID: 26513611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis.
    Rodriguez-Castro KI; Vitale A; Fadin M; Shalaby S; Zerbinati P; Sartori MT; Landi S; Pettinari I; Piscaglia F; Han G; Burra P; Simioni P; Senzolo M
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):34-42. PubMed ID: 30188408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients.
    Hayashi T; Takatori H; Horii R; Nio K; Terashima T; Iida N; Kitahara M; Shimakami T; Arai K; Kitamura K; Kawaguchi K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Toyama T; Okumura K; Kozaka K; Kaneko S
    BMC Gastroenterol; 2019 Dec; 19(1):217. PubMed ID: 31842768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.